Letter from the Editors
Last year we successfully introduced a new journal: The Journal of Rare Diseases and Orphan Drugs (JRDOD) is a peer-reviewed open-access medical journal that publishes original research, reviews, case reports, and letters covering a broad field of its specialty. We intend to publish articles stimulating to read, educate, and inform readers with the most up-to-date research in genetics, rare diseases, and new orphan drug development in different stages of clinical trials. Journal topics are centered on patients living with undiagnosed rare diseases, the importance of a diagnosis, individual approaches to treatments. We hope that this journal will increase awareness of many difficult to diagnosed and treat medical conditions.
2. Orphan Drug Act. 2049 – 2066. Available from: http://www.gpo.gov/fdsys/granule/STATUTE-96/STATUTE-96-Pg2049/content-detail.htm. [Accessed October 20, 2020].
3. Rare diseases and orphan products: accelerating research and development. Available from: http://www.nap.edu/catalog.php?record_id=12953. [Accessed October 20, 2020].
4. https://www.govinfo.gov/content/pkg/PLAW-107publ280/html/PLAW-107publ280.htm. [Accessed October 20, 2020].
5."Genetic and Rare Diseases Information Center". National Center for Advancing Translational Sciences, US National Institutes of Health. 2019. Retrieved 12 October 2019.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.